Search

Displaying results 4711 - 4720 of 10000 in total
  1. Drug

    Tamrintamab pamozirine

    go.drugbank.com/drugs/DB17222
    Investigational

    Tamrintamab pamozirine is an antibody-drug conjugate targeted against DPEP3.

  2. Drug

    UX053

    go.drugbank.com/drugs/DB18558
    Investigational

    UX053 is an mRNA encoding the human glycogen debranching enzyme.

  3. Drug

    GA31

    go.drugbank.com/drugs/DB32871
    Experimental

    GA31 is an 31-amino acid TREM-1 inhibitory peptide.

  4. Drug

    R-95845

    go.drugbank.com/drugs/DB07327
    Experimental

    R-95845 is an inhibitor of HIV-1 reverse transcriptase.

  5. Drug

    Alvocidib

    go.drugbank.com/drugs/DB03496
    Investigational

    Alvocidib is a synthetic flavonoid based on an extract from an Indian plant for the potential treatment of cancer.

  6. Drug

    S-23

    go.drugbank.com/drugs/DB07419
    Experimental

    An androgen receptor modulator.

  7. Drug

    Tosylchloramide

    go.drugbank.com/drugs/DB14708
    Investigational

    Tosylchloramide, also known as chloramine-T, is a chlorinated and deprotonated sulfonamide used as a mild disinfectant. It is not stable in the water dissolved form.

    Synonyms: N-chloro-p-toluenesulfonamide, N-chlorotoluene-p-sulfonamideCategories: Compounds used in a research, industrial, or household setting
  8. Drug

    GS-100

    go.drugbank.com/drugs/DB18337
    Investigational

    GS-100 is an adeno-associated virus serotype 9 virus particle containing viral DNA that includes an expression cassette containing the human NGLY1 gene coding sequence

  9. Drug

    Relebactam

    go.drugbank.com/drugs/DB12377
    ApprovedInvestigational

    [A181195,A181207] It includes a piperidine ring which reduces export from bacterial cells by producing a positive charge. … [label] It is considered to be a last-line treatment option and gained FDA approval as part of the combination product RecarbrioⓇ in July 2019.[L7568]

  10. Drug

    AD 337

    go.drugbank.com/drugs/DB05725
    Investigational

    AD 337 was under investigation in clinical trial NCT00377039 (A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia).